StockData
Lifecore Biomedical, Inc. logo

Lifecore Biomedical, Inc. (LFCR) stock

LFCRNasdaqPharmaceutical PreparationsFiscal year ends May 25
Financials through Q4 FY2025, quarter ended May 25, 2025Last filing: 10-Q on Nov 4, 2026Score 4/30
$6.40+0.01 (+0.16%)

Close on Nov 18, 2026Market cap $242.26MP/E –Yield –

Lifecore Biomedical free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Lifecore Biomedical's free cash flow for the twelve months ending May 25, 2025 was -$13.62M. For fiscal 2025 it was -$13.62M. The highest annual figure on record is $16.81M in fiscal 2012.

Annual free cash flow

PeriodPeriod endValueChange
FY2025May 25, 2025-$13.62M–
FY2024May 26, 2024-$18.14M–
FY2022May 29, 2022-$48.82M–
FY2021May 30, 2021-$2.79M–
FY2020May 31, 2020-$29.26M–
FY2019May 26, 2019-$28.71M–
FY2018May 27, 2018-$13.81M-302.1%
FY2017May 28, 2017$6.84M–
FY2016May 29, 2016-$18.93M-307.9%
FY2015May 31, 2015$9.11M+47.9%
FY2014May 25, 2014$6.16M-50.1%
FY2013May 26, 2013$12.35M-26.5%
FY2012May 27, 2012$16.81M+115.9%
FY2011May 29, 2011$7.79M+239.8%
FY2010May 30, 2010$2.29M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2025CQ2 2025May 25, 2025$3.25M-45.9%
Q3 FY2025CQ1 2025Feb 23, 2025-$4.26M–
Q2 FY2025CQ4 2024Nov 24, 2024-$8.58M–
Q1 FY2025CQ3 2024Aug 25, 2024-$4.04M–
Q4 FY2024CQ2 2024May 26, 2024$6.00M–
Q3 FY2024CQ1 2024Feb 25, 2024-$7.79M–
Q2 FY2024CQ4 2023Nov 26, 2023-$2.97M–
Q1 FY2024CQ3 2023Aug 27, 2023-$13.38M–
Q3 FY2023CQ1 2023Feb 26, 2023-$18.83M–
Q2 FY2023CQ4 2022Nov 27, 2022-$6.20M–
Q1 FY2023CQ3 2022Aug 28, 2022-$4.46M–
Q4 FY2022CQ2 2022May 29, 2022-$9.54M–
Q3 FY2022CQ1 2022Feb 27, 2022-$22.84M–
Q2 FY2022CQ4 2021Nov 28, 2021-$9.91M–
Q1 FY2022CQ3 2021Aug 29, 2021-$6.53M-151.8%
Q4 FY2021CQ2 2021May 30, 2021-$2.80M–
Q3 FY2021CQ1 2021Feb 28, 2021-$11.05M-345.7%
Q2 FY2021CQ4 2020Nov 29, 2020-$1.55M–
Q1 FY2021CQ3 2020Aug 30, 2020$12.60M–
Q4 FY2020CQ2 2020May 31, 2020-$2.80M–
Q3 FY2020CQ1 2020Feb 23, 2020$4.50M–
Q2 FY2020CQ4 2019Nov 24, 2019-$15.53M–
Q1 FY2020CQ3 2019Aug 25, 2019-$15.42M–
Q4 FY2019CQ2 2019May 26, 2019-$13.02M–
Q3 FY2019CQ1 2019Feb 24, 2019-$1.91M-121.2%
Q2 FY2019CQ4 2018Nov 25, 2018-$1.53M-158.3%
Q1 FY2019CQ3 2018Aug 26, 2018-$12.25M–
Q4 FY2018CQ2 2018May 27, 2018-$13.38M–
Q3 FY2018CQ1 2018Feb 25, 2018$9.00M-58.8%
Q2 FY2018CQ4 2017Nov 26, 2017$2.63M-63.0%
Q1 FY2018CQ3 2017Aug 27, 2017-$2.28M-129.1%
Q4 FY2017CQ2 2017May 28, 2017-$6.86M-961.6%
Q3 FY2017CQ1 2017Feb 26, 2017$21.88M–
Q2 FY2017CQ4 2016Nov 27, 2016$7.11M–
Q1 FY2017CQ3 2016Aug 28, 2016$7.84M–
Q4 FY2016CQ2 2016May 29, 2016$796.00K–
Q3 FY2016CQ1 2016Feb 28, 2016-$6.81M–

More Lifecore Biomedical figures

See a number that looks wrong?